Oxford Asset Management’s ProQR Therapeutics PRQR Stock Holding History

Oxford Asset Management’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-79,336	Closed	-$786K	–	1028
2019 Q4	$786K	Buy	79,336 +15,253	+24%	+$119K	0.02%	1007
2019 Q3	$369K	Buy	+64,083	New	+$512K	0.01%	1380
2019 Q1	–	Sell	-45,014	Closed	-$710K	–	1917
2018 Q4	$710K	Sell	45,014 -61,945	-58%	-$1.14M	0.02%	1026
2018 Q3	$2.08M	Buy	+106,959	New	+$1.14M	0.04%	644
2018 Q2	–	Sell	-20,199	Closed	-$62K	–	1877
2018 Q1	$62K	Sell	20,199 -6,970	-26%	-$22.4K	﹤0.01%	1551
2017 Q4	$86K	Buy	+27,169	New	+$97.5K	﹤0.01%	1533

Other funds holding PRQR

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Oxford Asset Management's PRQR Position: Q1 2020 in Review

Oxford Asset Management sold out of ProQR Therapeutics (PRQR) in Q1 2020, closing a stake of 79,336 shares — an estimated $786K sold.

Oxford Asset Management first reported a position in PRQR in Q4 2017 and held it in 6 quarters. The position peaked at $2.08M in Q3 2018. 44 funds tracked by Wall St. Rank hold PRQR as of Q1 2020.

Oxford Asset Management reported no remaining ProQR Therapeutics position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 79,336 ProQR Therapeutics shares in Q1 2020, an estimated $786K.
Oxford Asset Management first reported a position in ProQR Therapeutics in Q4 2017 and held it in 6 quarters.
Oxford Asset Management's ProQR Therapeutics position peaked at $2.08M in Q3 2018.
44 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.